共 50 条
[1]
Boelle PY(2019)Cystic fibrosis liver disease: outcomes and risk factors in a large cohort of French patients Hepatology 69 1648-1656
[2]
Debray D(2016)Cystic fibrosis Lancet 388 2519-2531
[3]
Guillot L(2019)The emerging burden of liver disease in cystic fibrosis patients: a UK nationwide study PLoS ONE 14 e0212779-400
[4]
Elborn JS(2022)Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis Aliment Pharmacol Ther 55 389-599
[5]
Toledano MB(2021)Emerging clinical perspectives in cystic fibrosis liver disease Curr Opin Pulm Med 27 593-1382
[6]
Mukherjee SK(2002)Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome Hepatology 36 1374-1347
[7]
Howell J(2017)Liver transplantation in adult cystic fibrosis: clinical, imaging, and pathological evidence of obliterative portal venopathy Liver Transpl 23 1342-1065
[8]
Scott J(2011)Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease Hepatology 53 1064-2136
[9]
Jones AM(2019)Obliterative portal venopathy without cirrhosis is prevalent in pediatric cystic fibrosis liver disease with portal hypertension Clin Gastroenterol Hepatol 17 2134-e13
[10]
Piper Hanley K(2017)Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension J Cyst Fibros 16 e11-126